New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Cellectar Biosciences, Inc. (CLRB) vs Palatin Technologies, Inc. (PTN)
- Cellectar Biosciences, Inc. CLRB 0.80 −9.09%
- Palatin Technologies, Inc. PTN 4.58 −7.10%
Cellectar Biosciences, Inc. and Palatin Technologies, Inc. are both Biotechnology companies. Cellectar Biosciences, Inc. and Palatin Technologies, Inc. are of similar size ($8.9M and $8.8M). Cellectar Biosciences, Inc. has the higher net margin (0.00% vs −385.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Cellectar Biosciences, Inc. leads on 8 and Palatin Technologies, Inc. on 3.
Valuation
Profitability
| Metric | CLRB | PTN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 70.18% |
| Operating margin | 0.00% | (392.22%) | 0.00% |
| Net margin | 0.00% | (385.44%) | 0.00% |
| Free cash flow margin | 0.00% | (333.15%) | 0.00% |
| Return on equity | (172.99%) | (1,495.52%) | (51.58%) |
| Return on assets | (116.54%) | (271.70%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack